Table 1.
Patient characteristics, matched pairs*, cross-sectional, Non-Bos/BOS
| Non-BOS (n = 20) | BOS (n = 20) | |||||||
|---|---|---|---|---|---|---|---|---|
| Diagnosis | Age | Tx type | Gender | Diagnosis | Age | Tx type | Gender | BOS |
| A1AT | 47 | SL | M | A1AT | 53 | SL | F | 3b |
| A1AT | 57 | SL | F | A1AT | 51 | BL* | F | 2b |
| CF | 31 | BL | M | CF | 25 | BL | M | 3b |
| CF | 35 | BL | M | CF | 21 | HL* | M | 3b |
| COPD | 47 | SL | F | COPD | 47 | SL | F | 2a |
| COPD | 47 | SL | F | COPD | 53 | SL | F | 2b |
| COPD | 53 | SL | F | COPD | 47 | SL | F | 3a |
| COPD | 53 | SL | F | COPD | 52 | SL | F | 2a |
| COPD | 55 | SL | F | COPD | 55 | SL | F | 2b |
| COPD | 64 | SL | M | COPD | 56 | SL | M | 3a |
| Eisenmenger | 32 | HL | M | Eisenmenger | 16 | HL | M | 3b |
| Eisenmenger | 30 | HL | M | Eisenmenger | 35 | HL | M | 3a |
| Eisenmenger | 40 | HL | F | Eisenmenger | 51 | HL | F | 3b |
| HUVS | 39 | BL | F | BAC | 47 | BL | F | 3a |
| IPF | 54 | SL | F | IPF | 51 | SL | F | 2a |
| PAH | 22 | HL | M | PAH | 29 | BL | M | 3b |
| PAH | 43 | BL | F | PAH | 26 | BL | F | 2b |
| PAH | 40 | BL | F | PAH | 33 | BL | F | 3a |
| PAH | 42 | HL | F | PAH | 45 | HL | F | 3b |
| PAH | 47 | BL | M | PAH | 51 | BL | M | 3a |
BOS bronchiolitis obliterans syndrome, A1AT α-1-antitrypsin deficiency, CF cystic fibrosis, COPD chronic obstructive pulmonary disease, HUVS hypocomplementemic urticarial vasculitis syndrome, BAC bronchioloalveolar carcinoma, IPF idiopathic pulmonary fibrosis, PAH pulmonary arterial hypertension, Tx transplantation, SL single-lung, BL bilateral lung, HL heart and bilateral lung, F female, M male
*Matched for pre-transplant diagnosis, age, gender, type of surgery and sampling time after surgery